Novo Nordisk A/S NOVO-B.CO DK Equity
DKK 295.25
-9.70 (-3.18%)
DKK · as of 2026-08-27 · marketstack
Novo Nordisk A/S (Nasdaq Copenhagen: NOVO-B.CO) closed at 295.25 DKK, -3.2%, on 2026-08-27, with a trailing P/E of 13.2, a return on equity of 60.7%, a net margin of 33.1% and 3-year sales growth of 20.4%. Institutional ownership, earnings history and filed financials are on the tabs below.
| Date | Event | What happened / filer | Source |
|---|---|---|---|
| No 8-K or Schedule 13D/G filings on record for NOVO-B.CO in the collected window (US SEC filers only). | |||
The US-listed sibling NVONOVO NORDISK A S carries this company's SEC filing history — the same company, the other listing.
Source: SEC EDGAR (public domain)
Every row is a filed document, checked against its EDGAR index.